Skip to main content

Anthrax Detection: Agencies Need to Validate Sampling Activities in Order to Increase Confidence in Negative Reults

GAO-05-493T Published: Apr 05, 2005. Publicly Released: Apr 05, 2005.
Jump To:
Skip to Highlights

Highlights

In September and October 2001, letters laced with Bacillus anthracis (anthrax) spores were sent through the mail to two U.S. senators and to members of the media. These letters led to the first U.S. cases of anthrax disease related to bioterrorism. In all, 22 individuals, in four states and Washington, D.C., contracted anthrax disease; 5 died. These cases prompted the Subcommittee to ask GAO to describe and assess federal agencies' activities to detect anthrax in postal facilities, assess the results of agencies' testing, and assess whether agencies' detection activities were validated.

Full Report

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs

Public Inquiries

Topics

AnthraxBiological agentsDisease detection or diagnosisDiseasesHealth hazardsHomeland securityInfectious diseasesInteragency relationsLaboratoriesPostal facilitiesPostal serviceStrategic planningTerrorismTest facilitiesTestingBioterrorismDisease surveillance